Madrigal Pharmaceuticals (MDGL) Enterprise Value (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Enterprise Value of -$232.2 million for Q1 2026, up 72.46% year-over-year from -$134.6 million in Q1 2025, and down 13.93% quarter-over-quarter from -$203.8 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Enterprise Value (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 17 years of Enterprise Value data on file, last reported at -$232.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$232.2 million, up 72.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$232.2 million (up 72.46% YoY), and the FY2025 annual result was -$203.8 million, down 94.05% from the prior year.
- Enterprise Value fell to -$232.2 million in Q1 2026 per MDGL's latest filing, from -$203.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$99.9 million in Q4 2023 and troughed at -$1.1 billion in Q3 2025.
- A 5-year average of -$488.8 million and a median of -$298.4 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value slumped 329.79% in 2024, then soared 72.46% in 2026.
- A 5-year view of Enterprise Value shows it stood at -$358.8 million in 2022, then surged by 72.15% to -$99.9 million in 2023, then retreated by 5.11% to -$105.0 million in 2024, then slumped by 94.05% to -$203.8 million in 2025, then fell by 13.93% to -$232.2 million in 2026.
- Business Quant data shows MDGL's Enterprise Value at -$232.2 million in Q1 2026, -$203.8 million in Q4 2025, and -$1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | -232.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -232.19 Mn |
| Dec 31, 2025 | -203.79 Mn |
| Sep 30, 2025 | -1.11 Bn |
| Jun 30, 2025 | -797.02 Mn |
| Mar 31, 2025 | -843.07 Mn |
| Dec 31, 2024 | -105.02 Mn |
| Sep 30, 2024 | -998.63 Mn |
| Jun 30, 2024 | -1.06 Bn |
| Mar 31, 2024 | -1.06 Bn |
| Dec 31, 2023 | -99.92 Mn |
| Sep 30, 2023 | -232.35 Mn |
| Jun 30, 2023 | -298.42 Mn |
| Mar 31, 2023 | -329.48 Mn |
| Dec 31, 2022 | -358.77 Mn |
| Sep 30, 2022 | -153.19 Mn |
| Jun 30, 2022 | -211.77 Mn |
| Mar 31, 2022 | -219.95 Mn |
| Dec 31, 2021 | -270.35 Mn |
| Sep 30, 2021 | -299.14 Mn |
| Jun 30, 2021 | -323.85 Mn |